The tale of two important biomarkers in the assessment and management of the septic patient and implications of the new CMS measures
The CMS Core Quality Measures (Sep-1) for sepsis are designed to aid in managing patients with severe sepsis and septic shock. This webinar will examine the CMS measures and how PCT and lactate assays play complimentary but different roles in assessing the risk of progression to sepsis and measuring response to treatment.
[vzaar_embed vzvd=”8170101″ ]
Following the presentation, our speaker will take part in an interactive Q&A session. Please come prepared with your questions on this topic.
[accordion title=”Featured Speakers” load=”show”]
Philipp Schuetz, MD, MPH
Devendra N. Amin MD, FCCM, FCCP
Morton Plant Hospital
[accordion title=”Moderator” load=”hide”]
Editorial Assistant, ADVANCE Healthcare Network
Information collected at registration may be shared with the sponsor. For more information about our sponsor, please visit: www.biomerieux-usa.com